Windlas Biotech IPO: Price band fixed at Rs 448-460, to raise Rs 401.53 crore
Windlas Biotech, the domestic pharmaceutical formulations contract development and manufacturing organization, has fixed the price band at Rs 448-460 per equity share for its public offer. The offer will open for subscription on August 4 and will close on August 6. Anchor book, if any, will open for a day on August 3, a day […]
Continue Reading